Kempe, Hans-Peter

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial

Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,829

Risk Factors for Retinopathy and DME in Type 2 Diabetes—Results from the German/Austrian DPV Database

Hammes, H.-P., Welp, R., Kempe, H.-P., Wagner, C., Siegel, E., Holl, R. W., & DPV Initiative—German BMBF Competence Network Diabetes Mellitus (2015) · PLOS ONE

Retinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

Cited by 131